At 4: 04 am on August 9, 1963, President John F. Kennedy waited silently in a dim basement corridor outside the hyperbaric oxygen chamber at Boston Children’s Hospital. He was exhausted, hollowed out by two sleepless nights and a mounting sense of foreboding. Earlier in the week, his administration had announced the signing of the Limited Nuclear Test Ban Treaty, a notable milestone in Cold War arms control. 1 But on that dark morning, geopolitics felt impossibly distant. Just beyond the chamber’s steel walls, the President’s newborn son was dying. Patrick Bouvier Kennedy had been born 39 hours earlier at an estimated 34 weeks’ gestation, weighing 2. 1 kg. From his first moments, he struggled to breathe. Cyanotic and frail, his shallow respirations and persistent grunting signaled a failing respiratory system. Physicians diagnosed hyaline membrane disease (HMD), the condition now recognized as neonatal respiratory distress syndrome (NRDS). 2NRDS arises from the failure of premature lungs to maintain alveolar stability and patency. As alveoli collapse, gas exchange falters, and immense strain is placed on an already immature cardiopulmonary system. Although Drs Mary Ellen Avery and Jeremiah Mead had demonstrated in 1959 that surfactant deficiency was central to HMD pathophysiology, 3 no effective replacement therapy yet existed. By 1963, treatment options remained profoundly limited. Management consisted largely of supplemental oxygen, sodium bicarbonate for correction of metabolic acidosis, and careful thermal control, with considerable variation among institutions. 4Mechanical ventilation, still in its infancy, offered little refuge. Early neonatal ventilators—crude adaptations of adult or small-animal devices—functioned on fixed cycles and predetermined pressures, rendering them poorly suited to the fragile lungs of premature infants; they did not synchronize to patient effort, provided no positive end-expiratory pressure, and were often as injurious as they were helpful. 5 Despite these limitations, early experimental efforts in NRDS, most notably by Dr Mildred Stahlman at Vanderbilt University and Dr Maria Delivoria-Papadopoulos at the University of Toronto, suggested that meaningful clinical benefit might be achievable. 6, 7 Such advances, while promising, remained tentative and provisional. For many institutions, including Boston Children’s Hospital, these developments were simply unavailable. As efforts to save Patrick intensified, his clinical team reached out to Delivoria-Papadopoulos for guidance. At the time, she had access to only a single neonatal respirator, already in use supporting another infant. 8 The episode captures an era in which neonatal critical care advanced unevenly, shaped as much by local access and institutional circumstance as by scientific progress. In the absence of more robust proven therapies, Patrick’s team turned to experimental measures. Hyperbaric oxygen therapy was among the few interventions believed capable of improving oxygen delivery in refractory hypoxemia. 9 Dr William Bernhard, a pediatric cardiothoracic surgeon, had previously employed hyperbaric oxygen during repairs of complex congenital heart defects. 10 Its application to NRDS, however, remained unfounded. 11 The decision to proceed underscored not faith in the treatment itself, but the limits of a field with no reliable alternatives left to offer. 12The attempt, bold as it was, would not succeed. Patrick Kennedy died shortly before dawn that Friday morning. When the news came, Kennedy quietly slipped away from his brothers, his aides, and his Secret Service detail. He retreated to the hospital’s boiler room, where, finally alone, he broke down in tears13—not merely as a president bearing the weight of the Cold War, but as a grieving father. Patrick’s death reverberated far beyond the hospital walls, prompting an outpouring of grief that spanned continents. 14 When President Kennedy appeared publicly for the first time after his son’s death, reporters noted his visible distress. 15 The scene stood in marked contrast to the composure and public resolve he ordinarily maintained, qualities later described by First Lady Jacqueline Kennedy as deliberate restraint in outward emotion. 16 Here was a man whose voice had guided the country through crisis, who would one day inspire a nation to reach the moon, now rendered silent by his own son’s suffering. The loss also reopened old wounds. Just 7 years earlier, the President and First Lady had endured the stillbirth of their daughter, Arabella, a tragedy that deepened their fear during Patrick’s brief life and magnified the heartbreak of his death. As leaders of the free world, they felt an obligation to project public strength amid private sorrow. 13 Patrick’s death shattered that illusion: even the most powerful man in the world was powerless to save one small life. Or so it seemed. Patrick’s death did more than shake a nation; it lent renewed urgency and visibility to efforts already under way to improve maternal and infant health. In the postwar United States, demographic shifts and changing public priorities drove a steady expansion of federal involvement in children’s health care, recasting childhood illness and survival as national responsibilities. 17 The Dependents’ Medical Care Act of 1956 extended medical coverage to military dependents, primarily spouses and children, shaping patterns of care focused on their specific health needs. 18 Federal priorities were further reflected in expanded Maternal and Child Health Bureau funding for childhood disability programs and newborn metabolic screening initiatives. 19 At the same time, private organizations were reshaping pediatric medicine: the March of Dimes, having declared victory over polio in the mid-1950s, redirected its vast resources toward birth defects, genetics, and perinatal disease. 20President Kennedy’s support for the creation of the National Institute of Child Health and Human Development (NICHD) in October 1962, nearly a year before Patrick’s birth, marked another critical inflection point in this evolving landscape. 21 The institute was driven in large measure by Kennedy’s sister, Eunice Kennedy Shriver, who urged her brother to strengthen federal investment in pediatric research. 22 For Shriver, the mission was personal. She had shared a deep bond with her sister Rosemary Kennedy, whose perinatal brain injury had resulted in lifelong disability. 23 What began as a family-driven push to advance maternal and child health took on new urgency after Patrick’s death. The highly publicized loss of a premature infant born to the nation’s most visible family brought unprecedented public and political attention to neonatal disease, hastening efforts long pursued by pediatricians to strengthen research, infrastructure, and care for the most vulnerable newborns. 12On October 24, 1963, 1 year after the founding of the NICHD and 8 weeks after Patrick’s death, President Kennedy announced the signing of the Maternal and Child Health and Mental Retardation Planning Amendments of 1963. The legislation allocated approximately 265 million, roughly equivalent to 2. 8 billion today, to neonatal research, preventive obstetric care, and efforts to combat intellectual disability. 24 In the decade that followed, the contours of neonatal care changed rapidly: antenatal corticosteroids boosted surfactant production and improved survival in preterm infants25; continuous positive airway pressure dramatically reduced mortality associated with NRDS26; Rho (D) immune globulin eliminated a once-common cause of fatal newborn anemia27; and pediatric-specific mechanical ventilators enabled sustained respiratory support for critically ill neonates. 28 These advances, supported by diverse public, private, and international funding sources, converged during a period of heightened public awareness and political prioritization, helping to further consolidate disparate innovations into the foundations of modern neonatology. The deficiencies that preceded these advances were stark. During the mid-20th century, progress in neonatal survival was modest. Between 1948 and 1963, neonatal mortality declined from approximately 22. 2 to 18. 2 deaths per 1000 live births, a reduction of 4. 0 deaths per 1000 over 15 years. 29, 30 In contrast, the 15 years following Patrick’s death were marked by more rapid improvement. Between 1963 and 1978, neonatal mortality fell from 18. 2 to approximately 9. 5 deaths per 1000 live births, a decline of 8. 7 deaths per 1000, corresponding to a reduction of nearly 50% and a rate of decline approximately twice that observed during the preceding postwar period. 30 This greater improvement occurred from a lower baseline and during a period in which neonatal deaths were disproportionately concentrated among premature and medically complex infants, groups historically least responsive to earlier advances in neonatal care. The enduring impact of this transformation is evident in contemporary outcomes. By 2023, neonatal mortality in the United States had declined to approximately 3. 65 deaths per 1000 live births, with mortality now concentrated primarily among infants with severe congenital anomalies rather than complications of prematurity. 31 Among infants born at Patrick’s gestational age of 34 weeks, survival now exceeds 99%. 31 The illness that claimed Patrick’s life has evolved from a diagnosis associated with substantial and unpredictable mortality to one that is now routinely survivable. 32 Had Patrick been born today, his death would almost certainly have been preventable. Today, the NICHD continues to support the very research that President Kennedy once dreamed might save a child like Patrick. We now speak in growth curves and ventilation strategies, in neurodevelopmental outcomes and high-risk follow-up clinics. Yet beneath these hard-won gains lies an unfinished promise. Pediatric research still commands less than 13% of the National Institutes of Health budget. 33 Workforce shortages, disparities in access, and public inattention threaten to slow the arc of progress. 34 Even as neonatal survival has improved and care has grown ever more complex, recent decades have been marked less by paradigm-shifting breakthroughs than by incremental refinements, 35 a warning that progress, once achieved, can just as easily stall. History suggests, however, that when the nation chooses to invest in its youngest lives, transformation follows. The question is not whether such change is possible, but whether our leaders will again find the will to make it so.
Jonathan A. Hermel (Tue,) studied this question.